Outcomes of robotic‐assisted liver surgery versus laparoscopic liver surgery for treatment of stage I hepatocellular carcinoma

Background This article investigated whether robotic‐assisted liver surgery versus laparoscopic liver surgical treatment of hepatocellular carcinoma (HCC) has similar or different short‐ and long‐term clinical outcomes. Methods A total of 3049 patients from the National Cancer Database who received...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2022-02, Vol.128 (4), p.762-769
Hauptverfasser: Duong, Linh M., Cai, Hui, Shrubsole, Martha J., Bailey, Christina E., Idrees, Kamran, Shu, Xiao‐Ou
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background This article investigated whether robotic‐assisted liver surgery versus laparoscopic liver surgical treatment of hepatocellular carcinoma (HCC) has similar or different short‐ and long‐term clinical outcomes. Methods A total of 3049 patients from the National Cancer Database who received minimally invasive surgery (ie, robotic or laparoscopic surgery) for stage I HCC cancers between 2010 to 2015, of which 123 had robotic and 2926 had laparoscopic surgeries performed, were identified. Logistic regression was applied to evaluate short‐term outcomes. Cox proportional hazards models were applied to estimate all‐cause mortality at 1‐year, 3‐years, and 5‐years after surgery, adjusting for potential confounders. Propensity score‐matched analyses were conducted to compare long‐term outcomes between robotic and laparoscopic surgeries. Results Robotic surgery was associated with improved overall survival, with 1‐, 3‐, and 5‐year survival rates (SRs) of 0.92, 0.75, and 0.63 compared with laparoscopic surgery SRs of 0.86, 0.60, and 0.45, respectively (P value
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.33979